ATHOS KG
Holzkirchen, Bavariaathos.de
Overview
ATHOS KG is the single family office of the German entrepreneurial family Strüngmann, specifically brothers Andreas and Thomas Strüngmann who founded the generic drug manufacturer Hexal. It functions as a long-term, value-based investor with a primary focus on healthcare, life sciences, biotechnology, and technology-driven companies. The firm is known for its significant and foundational investment in BioNTech, the company that developed a widely used COVID-19 vaccine.
Portfolio Companies
4
Website
athos.deInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Doctolib | Apr 2026 | Secondary | Co-investor |
| Bactolife | Jan 2026 | Series B | Co-investor |
| AMSilk | May 2021 | Series C | Co-investor |
| WS Audiology | Mar 2019 | M&A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?